These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 17382715)
1. Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. Weizer AZ; Joshi D; Daignault S; Kinnaman M; Hussain M; Montie JE; Zhang Y; Lee CT J Urol; 2007 Apr; 177(4):1287-93. PubMed ID: 17382715 [TBL] [Abstract][Full Text] [Related]
2. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Tran E; Souhami L; Tanguay S; Rajan R Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
4. [Radical cystectomy for invasive bladder carcinoma in patients 75 years old or older]. Uekado Y; Inagaki T; Hagino K; Suzuki A; Shinka T Hinyokika Kiyo; 2005 Aug; 51(8):547-51. PubMed ID: 16164271 [TBL] [Abstract][Full Text] [Related]
5. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer. Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798 [TBL] [Abstract][Full Text] [Related]
6. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771 [TBL] [Abstract][Full Text] [Related]
7. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301 [TBL] [Abstract][Full Text] [Related]
8. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Hollenbeck BK; Miller DC; Taub D; Dunn RL; Underwood W; Montie JE; Wei JT Urology; 2004 Aug; 64(2):292-7. PubMed ID: 15302481 [TBL] [Abstract][Full Text] [Related]
9. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Prout GR; Wesley MN; Yancik R; Ries LA; Havlik RJ; Edwards BK Cancer; 2005 Oct; 104(8):1638-47. PubMed ID: 16130136 [TBL] [Abstract][Full Text] [Related]
10. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. Margel D; Tal R; Baniel J J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837 [TBL] [Abstract][Full Text] [Related]
11. Impact of the level of muscle invasion in organ-confined bladder cancer. Girgin C; Sezer A; Delibaş M; Sahin O; Oder M; Dinçel C Urol Int; 2007; 78(2):145-9. PubMed ID: 17293655 [TBL] [Abstract][Full Text] [Related]
12. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer? Hafron J; Mitra N; Dalbagni G; Bochner B; Herr H; Donat SM J Urol; 2005 May; 173(5):1513-7. PubMed ID: 15821470 [TBL] [Abstract][Full Text] [Related]
13. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628 [TBL] [Abstract][Full Text] [Related]
14. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Sogni F; Brausi M; Frea B; Martinengo C; Faggiano F; Tizzani A; Gontero P Urology; 2008 May; 71(5):919-23. PubMed ID: 18355900 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296 [TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818 [TBL] [Abstract][Full Text] [Related]
17. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? Chamie K; Hu B; Devere White RW; Ellison LM BJU Int; 2008 Aug; 102(3):284-90. PubMed ID: 18410437 [TBL] [Abstract][Full Text] [Related]
19. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer. Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855 [TBL] [Abstract][Full Text] [Related]
20. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy. Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]